Organism name | Erythrina variegata |
---|---|
Genus | Erythrina |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Erythrina variegata |
---|---|
Linked NCBI taxonomy ID | 3845 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00009516
![]() |
6,8-Diprenylgenistein
/ 8-(gamma,gamma-Dimethylallyl)wighteone / 5,7,4'-Trihydroxy-6,8-diprenylisoflavone |
CHEMBL494252
|
12 / 14 / 11 | No. 14 | No. 15 |
![]() |
||
C00019741
![]() |
Eryvarin E
/ 3-Hydroxy-9-methoxy-2,10-diprenylpterocarpan |
No. 14 | No. 15 |
![]() |
||||
C00018965
![]() |
Erysubin F
|
CHEMBL2159045
|
1 / 0 / 0 | No. 14 | No. 15 |
![]() |
||
C00010027
![]() |
Erycristagallin
/ 3,9-Dihydroxy-2,10-diprenylpterocarpene |
CHEMBL462699
|
1 / 0 / 0 | No. 14 | No. 15 |
![]() |
||
C00002586
![]() |
Wighteone
/ Erythrinin B / 5,7,4'-Trihydroxy-6-prenylisoflavone |
CHEMBL393222
|
2 / 1 / 1 | No. 15 | No. 15 |
![]() |
||
C00018966
![]() |
Eryvarin D
|
CHEMBL1097045
|
No. 15 | No. 15 |
![]() |
|||
C00002555
![]() |
Osajin
|
CHEMBL238188
|
36 / 50 / 70 | No. 18 | No. 15 |
![]() |
||
C00009948
![]() |
Euchrenone b9
|
No. 18 | No. 15 |
![]() |
||||
C00009521
![]() |
Auriculatin
|
No. 18 | No. 15 |
![]() |
||||
C00009514
![]() |
Scandenone
/ Warangalone |
CHEMBL458134
|
C105205
|
No. 18 | No. 15 |
![]() |
||
C00018981
![]() |
(-)-Bidwillon A
/ 7,2',4'-Trihydroxy-6,8-diprenylisoflavanone |
No. 19 | No. 14 |
![]() |
||||
C00009492
![]() |
Alpinumisoflavone
|
CHEMBL238628
|
C000154
|
3 / 1 / 1 | 1 / 0 | No. 24 | No. 15 |
![]() |
C00019381
![]() |
Bidwillon C
/ 4'-Hydroxy-6'',6''-dimethylpyrano[2'',3'':7,8]isoflavone |
CHEMBL1214836
|
1 / 1 / 1 | No. 24 | No. 15 |
![]() |
||
C00009431
![]() |
Erythrinin A
|
No. 24 | No. 15 |
![]() |
||||
C00008197
![]() |
Isobavachin
|
CHEMBL491534
|
C468753
|
2 / 0 | No. 28 | No. 14 |
![]() |
|
C00018985
![]() |
Bidwillon B
|
No. 39 |
![]() |
|||||
C00018984
![]() |
Orientanol F
/ 2',4'-Dihydroxy-6-prenyl-6'',6''-dimethylpyrano[2'',3'':7,8]isoflavanone |
No. 39 |
![]() |
|||||
C00019725
![]() |
Eryvarin B
/ 7,4'-Dihydroxy-5''-(1-hydroxy-1-methylethyl)-8'-prenyl-6'',6''-dimethyl-4'',5''-dihydropyrano[2'',3'':5,6]isoflavone |
No. 47 | No. 15 |
![]() |
||||
C00019069
![]() |
Erysubin C
/ (6aR,11aR)-2-Carboxyaldehyde-9-hydroxy-3-methoxypterocarpan |
No. 66 | No. 15 |
![]() |
||||
C00019740
![]() |
Eryvarin C
/ (3R)-2',4'-Dihydroxy-6'',6''-dimethylpyrano[2'',3'':7,6]isoflavan |
No. 135 | No. 15 |
![]() |
||||
C00002559
![]() |
Phaseolin
/ (-)-Phaseollin |
CHEMBL448350
|
No. 135 | No. 15 |
![]() |
|||
C00009501
![]() |
Erythrinin C
|
No. 139 |
![]() |
|||||
C00019377
![]() |
Erythrivarone A
/ 5,4'-Dihydroxy-6'',6''-dimethyl-4'',5''-dihydropyrano[2'',3'':7,6]isoflavone |
No. 139 |
![]() |
|||||
C00019738
![]() |
Eryvarin K
/ 3,9-Dihydroxy-8-methoxy-4-prenylpterocarpan |
CHEMBL1079408
|
1 / 0 / 0 | No. 188 | No. 15 |
![]() |
||
C00018899
![]() |
Orientanol B
/ 3-O-Methylcalopocarpin |
CHEMBL465985
|
No. 188 | No. 15 |
![]() |
|||
C00002558
![]() |
Phaseollidin
|
CHEMBL508534
|
C085158
|
1 / 0 / 0 | No. 188 | No. 15 |
![]() |
|
C00019739
![]() |
Eryvarin L
/ 6,4'-Dihydroxy-2',5'-dimethoxy-2-arybenzofuran |
No. 210 | No. 15 |
![]() |
||||
C00002893
![]() |
Oxyresveratrol
/ 2,3,4,5'-Tetrahydroxystilbene |
CHEMBL43065
|
20 / 32 / 49 | No. 295 | No. 13 |
![]() |
||
C00002515
![]() |
Cristacarpin
/ Erythrabyssin I |
CHEMBL454849
|
C085157
|
2 / 1 / 1 | No. 325 | No. 15 |
![]() |
|
C00019724
![]() |
Eryvarin A
/ (6aS,11aS,5'S)-3,6a,5'-Trihydroxy-6',6'-dimethyl-4',5'-dihydropyrano[2',3':9,10]pterocarpan |
CHEMBL269337
|
No. 325 | No. 15 |
![]() |
|||
C00009664
![]() |
Folitenol
|
CHEMBL551155
|
1 / 0 / 0 | No. 352 | No. 15 |
![]() |
||
C00018967
![]() |
Orientanol C
|
No. 352 | No. 15 |
![]() |
||||
C00018947
![]() |
Bidwillol A
|
No. 400 |
![]() |
|||||
C00019735
![]() |
Eryvarin H
/ 7,4'-Dihydroxy-2',5'-dimethoxyisoflav-3-ene |
No. 400 |
![]() |
|||||
C00018969
![]() |
Sigmoidin K
/ 3,9-Dihydroxy-2,10-diprenylcoumestan |
CHEMBL1095262
|
C090620
|
No. 436 | No. 17 |
![]() |
||
C00027356
![]() |
Erythrartine
/ (+)-Erythrartine / 11-Hydroxyerysotrine |
CHEMBL217996
|
No. 446 | No. 4 |
![]() |
|||
C00010024
![]() |
2-Prenyl-6a-hydroxyphaseollidin
/ 3,6a,9-Trihydroxy-2,10-diprenylpterocarpan |
No. 460 |
![]() |
|||||
C00009669
![]() |
Erythrabyssin II
/ 3,9-Dihydroxy-2,10-diprenylpterocarpan |
CHEMBL455372
|
1 / 0 / 0 | No. 460 |
![]() |
|||
C00018930
![]() |
Erystagallin A
|
CHEMBL1088462
|
1 / 0 / 0 | No. 460 |
![]() |
|||
C00019737
![]() |
Eryvarin J
/ 3,9-Dihydroxy-2,4-diprenylpterocarpan |
No. 460 |
![]() |
|||||
C00019378
![]() |
Erythrivarone B
|
No. 724 |
![]() |
|||||
C00000615
![]() |
Caffeic acid
|
CHEMBL145
CHEMBL1320034 |
68 / 64 / 63 | No. 904 | No. 6 |
![]() |
||
C00019068
![]() |
Laburnetin
/ 5,7,4',2''-Tetrahydroxy-6-[3''-methyl-3''-butenyl]isoflavone |
No. 984 |
![]() |
|||||
C00020453
![]() |
Eryvariestyrene
|
No. 1271 | No. 13 |
![]() |
||||
C00019736
![]() |
Eryvarin I
/ 3-Hydroxy-2'-methoxy-6'',6''-dimethylpyrano[2'',3'':4',3']isoflav-3-ene |
No. 2189 |
![]() |
|||||
C00002074
![]() |
Stachydrine
|
CHEMBL394450
CHEMBL1456892 CHEMBL1986864 |
10 / 8 / 12 | No. 2627 | No. 1 |
![]() |
||
C00001854
![]() |
beta-Erythroidine
|
C004873
|
No. 4287 | No. 4 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000615 C00002558 C00009492 C00009664 C00009669 C00018930 C00018965 C00019738 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000615 C00002515 C00002586 C00009492 C00019381 | 1 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00000615 C00002555 C00002893 C00009516 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000615 C00002074 C00002555 | 0 / 1 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000615 C00002074 C00002555 | 1 / 2 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002515 C00002586 C00009492 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000615 C00002074 C00002893 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000615 C00002074 C00002555 | 2 / 5 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002555 C00002893 C00009516 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000615 C00002555 C00009516 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000615 C00002555 C00009516 | 4 / 3 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000615 C00002893 | 2 / 2 |
P06746 | DNA polymerase beta | Enzyme | C00000615 C00002555 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00002555 C00009516 | 6 / 4 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000615 C00002555 | 1 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002555 C00009516 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000615 C00002555 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000615 C00002555 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000615 C00002893 | 0 / 3 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002555 C00009516 | 2 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000615 C00002555 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002555 C00009516 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000615 C00002074 | 1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00000615 C00002555 | 11 / 10 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000615 C00002555 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000615 C00002074 | 3 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002893 C00009516 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00000615 C00002893 | 1 / 3 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00002555 C00009516 | 0 / 3 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002555 C00002893 | 7 / 37 |
P14679 | Tyrosinase | Oxidoreductase | C00000615 C00002893 | 4 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000615 C00002074 | 0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002074 C00002555 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000615 C00002893 | 0 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000615 C00002893 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002555 C00009516 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000615 C00002074 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000615 C00002555 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002555 C00002893 | 2 / 2 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002555 C00002893 | 4 / 2 |
O75496 | Geminin | Unclassified protein | C00002555 C00009516 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002555 C00002893 | 1 / 1 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000615 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002074 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00002555 | 1 / 1 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000615 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000615 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000615 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000615 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00000615 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000615 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000615 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000615 | 1 / 8 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002555 | 1 / 1 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002555 | 0 / 0 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00000615 | 1 / 1 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00000615 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00002893 | 4 / 4 |
P06280 | Alpha-galactosidase A | Enzyme | C00000615 | 1 / 1 |
P45452 | Collagenase 3 | M10A | C00002893 | 1 / 1 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00000615 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00002893 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000615 | 1 / 2 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000615 | 0 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000615 | 3 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000615 | 3 / 3 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000615 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000615 | 2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000615 | 5 / 2 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000615 | 1 / 1 |
P37840 | Alpha-synuclein | Unclassified protein | C00002893 | 4 / 2 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000615 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002555 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002555 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002555 | 0 / 0 |
P39900 | Macrophage metalloelastase | M10A | C00002893 | 0 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000615 | 1 / 0 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00000615 | 4 / 2 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000615 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000615 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000615 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000615 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00002893 | 1 / 0 |
P04054 | Phospholipase A2 | Enzyme | C00010027 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000615 | 1 / 1 |
Q12794 | Hyaluronidase-1 | Enzyme | C00000615 | 1 / 2 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000615 | 3 / 0 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00000615 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000615 | 0 / 0 |
O00167 | Eyes absent homolog 2 | Enzyme | C00002555 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000615 | 2 / 2 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000615 | 1 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000615 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00000615 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002555 | 4 / 1 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00000615 | 0 / 0 |
P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | C00000615 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000615 | 0 / 0 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000615 | 1 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00002555 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00009492
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00008197
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00008197
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P84022
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04637 |
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
|
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|